
A landmark report has shown that English life expectancy has stalled for the first time in a century, and reversed …

Esperion’s ATP Citrase Lyase (ACL) inhibitor Nexletol (bempedoic acid) has secured approval from the FDA, it has emerged. It is …

Sanofi plans to create a new company in Europe dedicated to the production and marketing of active pharmaceutical ingredients (API). …

Disruption to the US drug production pipeline from the coronavirus could hurt its domestic supply of 150 drugs. US senators …

Every year, Veeva asks clinical professionals to take part in the Veeva Unified Clinical Operations Survey to help the industry …

The FDA has just authorised its first adjuvanted quadrivalent influenza vaccine, it has been announced. Seqirus’ Fluad Quadrivalent (influenza vaccine, adjuvanted) …

Chinese biotech firm Clover Biopharmaceuticals has joined the race to develop interventions against the ongoing coronavirus outbreak with the announcement …

Eli Lilly’s Trulicity (duraglutide) has been awarded marketing authorisation from the FDA as a therapy to reduce major adverse cardiovascular …

Lundbeck’s Vyepti (eptinezumab-jjmr) has secured approval from the FDA, it has emerged, for the prevention of migraine in adult patients. …

Baudax Bio has revealed the FDA approval of its non-opioid painkiller Anjeso (meloxicam injection) as a therapy for the management …

German-based drugmaker Merck KGaA has confirmed its intention to divest its allergy business Allergopharma to Dermapharm, another German manufacturer of …

Israeli firm Teva has shared disappointing results for its vesicular monoamine transporter 2 (VMAT2) Austedo (deutetrabenazine) after it failed to …

The coronavirus is again in the news, with the Indian government considering banning exports of medicine as the epidemic threatens …

On Thursday, Ukrainian protestors attacked buses carrying people evacuated from Wuhan in China, the epicenter of the coronavirus outbreak. The …

MIT researchers have identified a new antibiotic compound using a machine-learning algorithm. In the laboratory tests, the drug killed many …

MSD’s blockbuster immunotherapy Keytruda has been stopped in its tracks by the FDA after the US regulator rejected its application …

Bristol-Myers Squibb has announced updated results from trialing Opdivo (nivolumab) plus Yervoy (ipilimumab) versus sunitinib in patients with previously untreated …

GlaxoSmithKline has struck a deal to access two Immatics T-cell receptor (TCR) therapeutics. The deal sees GSK pay $50 million …

The FDA covered a lot of ground in 2019 when it came to generic drugs, awarding at least tentative approval …

Two Japanese passengers on a quarantined cruise ship have died after contracting the coronavirus.The pair were both in their 80’s …